House Majority Leader Steve Scalise, a top contender for the next House speaker, says his doctors are very encouraged with the progress of his treatment for cancer.
The addition of PARP inhibitors for the treatment of patients with BRCA-mutated advanced ovarian cancer has provided clinicians with a stronger set of treatment options. Looking at how the BRCA mutation responds to these inhibitors is then vital to deciding the patient’s treatment path.
Thermo Fisher Scientific, a global leader in scientific services, has received FDA clearance for the Thermo Scientific™ B·R·A·H·M·S™ CgA II KRYPTOR™ immunoassay, marking the first FDA-approved chromogranin A (CgA) test. Click to read more.
The Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with the Advanced Practitioner Society for Hematology and Oncology (APSHO), today announced the launch of Make It HAPPen™, a multi-year effort designed to recognize and support Advanced Practice Providers (APPs) in the life-changing care .
/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with the Advanced Practitioner Society for Hematology and Oncology.